Eli Lilly said copycat versions of Zepbound that add B12 result in potentially dangerous impurities. The compounding industry ...
Eli Lilly and Co LLY on Thursday issued a public warning about potential safety risks linked to compounded tirzepatide ...
Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple ...
Testing identified significant impurity formation when tirzepatide is compounded with B12 variants, suggesting chemical incompatibility that is not evaluated under FDA review pathways. Uncertainty ...
Eli Lilly warns compounded tirzepatide mixed with B12 may contain impurities and safety risks as FDA tightens GLP-1 rules—get ...
Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities.
Shares of Eli Lilly and Company (NYSE:LLY) slipped about 1% in early Thursday trading after the drugmaker cautioned about potential safety concerns tied to compounded versions of tirzepatide mixed ...